| |
p-interaction*
|
All VTE
|
Pulmonary Embolism
|
Deep vein thrombosis
|
Primary
|
Secondary
|
|---|
|
Group O
|
|
hypertension
|
0.01
|
1.14 (0.95: 1.38)
|
1.21 (0.88: 1.68)
|
1.10 (0.88: 1.39)
|
1.56 (1.07: 2.27)
|
1.03 (0.83: 1.28)
|
|
dyslipidaemia
|
0.78
|
0.70 (0.58: 0.85)
|
1.10 (0.78: 1.53)
|
0.60 (0.44: 0.83)
|
0.67 (0.42: 1.09)
|
0.82 (0.64: 1.06)
|
|
diabetes
|
0.82
|
0.68 (0.36: 1.29)
|
0.55 (0.20: 1.50)
|
0.79 (0.35: 1.80)
|
1.31 (0.47: 3.66)
|
0.51 (0.23: 1.17)
|
|
Group non-O
|
|
hypertension
|
–
|
0.97 (0.85: 1.11)
|
1.05 (0.82: 1.36)
|
0.95 (0.81: 1.10)
|
0.78 (0.60: 1.01)
|
1.05 (0.90: 1.23)
|
|
dyslipidaemia
|
–
|
0.78 (0.69: 0.88)
|
0.78 (0.63: 0.97)
|
0.78 (0.67: 0.90)
|
0.63 (0.48: 0.83)
|
0.83 (0.72: 0.95)
|
|
diabetes
|
–
|
0.78 (0.51: 1.18)
|
1.19 (0.66: 2.15)
|
0.56 (0.31: 1.01)
|
1.02 (0.47: 2.19)
|
0.71 (0.43: 1.16)
|
- * interaction with all-VTE
- * adjusted on education level, statin use, menopause, MHT use, parity, type of menopause, family history of CVD and BMI
